Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919750 · ClinicalTrials.gov registry record
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 1,258
- Enrollment target
NCT00919750: Completed study, sponsored by Children's Oncology Group.
NCT00919750 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 1,258 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00919750 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 1,258 participants
- Enrollment target
Study Summary
The purpose of this study is to collect and store brain tissue samples and blood from children with brain cancer that will be tested in the laboratory. Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.
Interventions
- OTHER Cytology Specimen Collection Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,258 participants |
| Start Date | 2004-02-16 |
| Est. Completion | 2018-06-30 |
What the finished NCT00919750 record still lists
NCT00919750 is an observational study that tracks outcomes without assigning an intervention. Its 1,258 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Cytology Specimen Collection Procedure is the first listed.
NCT00919750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00919750 about?
NCT00919750 is a clinical study titled "Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors". The purpose of this study is to collect and store brain tissue samples and blood from children with brain cancer that will be tested in the laboratory. Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.
What is the current status of trial NCT00919750?
This trial is currently completed. The enrollment target is 1,258 participants. The study started on 2004-02-16. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT00919750?
The interventions under investigation include: Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT00919750?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI